“Our goal is to build a strong evidence base for proactive, preventive healthcare through collaborative, clinically grounded research," says the company's head of research. 

Harrison.ai recently completed a $112M Series C financing round, which placed the company’s value at approximately $551 million (USD), Forbes Australia reports. 

The implementation will span three hospitals in Sweden’s Stockholm Region, supporting between 200,000 and 250,000 breast imaging exams annually.